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Case Report
Excessive Gas Exchange Impairment During Exercise in
a Subject with a History of Bronchopulmonary Dysplasia
and High Altitude Pulmonary Edema
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ABSTRACT
Lovering, Andrew T., Lee M. Romer, Hans C. Haverkamp, John S. Hokanson, and Marlowe W.
Eldridge. Excessive gas exchange impairment during exercise in a subject with a history of bron-
chopulmonary dysplasia and high altitude pulmonary edema. High Alt. Med. Biol. 8:62–67,
2007.—A 27-year-old male subject (V˙O2max, 92% predicted) with a history of bronchopulmonary
dysplasia (BPD) and a clinically documented case of high altitude pulmonary edema (HAPE)
was examined at rest and during exercise. Pulmonary function testing revealed a normal forced
vital capacity (FVC, 98.1% predicted) and diffusion capacity for carbon monoxide (DLCO, 91.2%
predicted), but significant airway obstruction at rest [forced expiratory volume in 1 sec (FEV1),
66.5% predicted; forced expiratory flow at 50% of vital capacity (FEF50), 34.3% predicted; and
FEV1/FVC  56.5%] that was not reversible with an inhaled bronchodilator. Gas exchange wors-
ened from rest to exercise, with the alveolar to arterial PO2 difference (AaDO2) increasing from
0 at rest to 41 mmHg at maximal normoxic exercise (V˙O2  41.4 mL/kg/min) and from 11 to
31 mmHg at maximal hypoxic exercise (V˙O2  21.9 mL/kg/min). Arterial PO2 decreased to 67.8
and 29.9 mmHg at maximal normoxic and hypoxic exercise, respectively. These data indicate
that our subject with a history of BPD is prone to a greater degree of exercise-induced arterial
hypoxemia for a given V˙O2 and FIO2 than healthy age-matched controls, which may increase
the subject’s susceptibility to high altitude illness.
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sia; hypoxia; intrapulmonary shunt
1University of Wisconsin School of Medicine and Public Health, Department of Population Health Sciences, John
Rankin Laboratory of Pulmonary Medicine, Madison, Wisconsin.
2University of Wisconsin School of Medicine and Public Health, Department of Pediatrics, Cardiology, Madison,
Wisconsin.
3University of Wisconsin School of Medicine and Public Health, Department of Pediatrics, Critical Care Medicine
and Biomedical Engineering, Madison, Wisconsin.
GAS EXCHANGE IMPAIRMENT IN A HAPE-SUSCEPTIBLE SUBJECT 63
INTRODUCTION
HIGH ALTITUDE PULMONARY EDEMA (HAPE) isa noncardiogenic, permeability edema
that occurs with rapid ascent to high altitudes
(Schoene, 2004; Bartsch et al., 2005). Pulmonary
function at sea level in subjects susceptible to
HAPE (HAPE-s) is normal (Eldridge et al.,
1996), and gas exchange as determined by the
alveolar to arterial PO2 difference (AaDO2) is not
different from control subjects at rest or during
near maximal exercise (85% V˙O2max) in nor-
moxia or hypoxia (Podolsky et al., 1996). Fur-
thermore, HAPE-s subjects may have aug-
mented flow-dependent pulmonary vascular
reactivity (Eldridge et al., 1996).
We present data demonstrating excessive gas
exchange impairment during normoxic and hy-
poxic exercise in an otherwise asymptomatic
male subject with a history of bronchopul-
monary dysplasia (BPD) and a physician-doc-
umented incidence of HAPE at a moderate al-
titude (2927 m). Bronchopulmonary dysplasia
is a chronic lung disease that typically devel-
ops in preterm infants who require prolonged
mechanical ventilation and/or high inspired
oxygen concentrations (Bhandari and Bhan-
dari, 2003; Hjalmarson and Sandberg, 2005). In-
dividuals with BPD have poor pulmonary
function at term (Hjalmarson and Sandberg,
2005) resulting from abnormal alveolarization
(Margraf et al., 1991) and abnormal pulmonary
vascularization (Bhatt et al., 2001; Parker and
Abman, 2003). Furthermore, many BPD pa-
tients have mild pulmonary hypertension and
brisk pulmonary vascular reactions to hypoxia
(Stenmark and Abman, 2005). These pul-
monary characteristics should predispose indi-
viduals with BPD to gas exchange abnormali-
ties during hyperdynamic conditions such as
exercise and therefore may increase their risk
for developing HAPE or other altitude ill-
nesses.
CASE REPORT
A normally fit (92% predicted V˙O2max) 27-
year-old male subject, with a clinically docu-
mented case of HAPE at 2927 m at age 13 yr,
was brought to the laboratory to be evaluated
for exercise-induced intrapulmonary arteriove-
nous shunting. Based on our previous studies
(Eldridge et al., 2004), approximately 90% of
subjects tested have intrapulmonary shunting
during exercise. We have hypothesized that in-
trapulmonary arteriovenous shunts may act as
pressure relief valves during periods of high
pulmonary pressures and blood flows. Because
subjects with HAPE have an accentuated pul-
monary vascular response to hypoxic exercise
(Eldridge et al., 1996), we hypothesized that
HAPE-susceptible subjects may in fact not have
exercise-inducible intrapulmonary shunts. Sub-
sequently, we found that the subject was born
premature at an estimated gestational age of 32
to 33 weeks and a birth weight of 1588 g. He
developed respiratory distress at 5 h of age, re-
quiring oxygen therapy (25%–30% O2) for 54
days. He did not receive surfactant and never
required intubation or mechanical ventilation.
He was discharged home with a diagnosis of
BPD.
Anthropometric, pulmonary function and
lung diffusion capacity for carbon monoxide
(DLCO) are shown in Table 1. Pulmonary func-
tion was determined according to ATS stan-
dards (1995). Forced vital capacity (FVC) and
DLCO were normal. However, the subject
showed significant airway obstruction with
reductions in (1) forced expiratory volume in
1 sec (FEV1), (2) forced expiratory flow at 50%
of vital capacity (FEF50), and (3) FEV1/FVC
(Table 1). On a separate day, pulmonary func-
tion was assessed before and after inhalation
of a -agonist (albuterol® aerosol, 180 g). 
-agonist administration resulted in very mi-
nor improvements in pulmonary function
(Table 1).
The subject completed two incremental cycle
ergometer exercise tests to exhaustion while
breathing normoxic (FIO2  0.209) and hypoxic
(FIO2  0.12) gas, respectively. The order of the
tests was randomized, with the subject per-
forming the hypoxic exercise first. The tests
were separated by 1 h. The initial work rate was
set at 65 W, with the work rate increased by 30
W every 2 min until volitional exhaustion. Api-
cal four-chamber saline contrast echocardio-
grams with harmonic imaging were performed
at rest (Cypress Ultrasound Systems, Acu-
son/Semins, Mountain View, CA) during the
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last minute of each 2-min exercise stage and 3
min after the final exercise load, as described
previously (Eldridge et al., 2004). The subject
demonstrated intrapulmonary shunting at rest
in hypoxia and during submaximal exercise in
both normoxia and hypoxia (Fig. 1). Arterial
blood samples were drawn anaerobically over
10 to 20 sec during each exercise stage and an-
alyzed for PO2, PCO2, and pH with a blood-gas
analyzer calibrated with tonometered blood
(ABL300, Radiometer). The subject had normal
resting gas exchange while breathing normoxic
air, as indicated by an alveolar-to-arterial PO2
difference (AaDO2) of 0 mmHg; while breath-
ing hypoxic gas, it widened to 11 mmHg (Fig.
1). With both normoxic and hypoxic exercise,
the AaDO2 widened significantly to 41 and 31
mmHg, respectively, contributing to significant
decreases in arterial oxygenation, even during
normoxic exercise (Fig. 2). Arterial PCO2 re-
mained relatively constant throughout nor-
moxic exercise and was 38.7 mmHg at maxi-
mal exercise (Fig. 2). We were surprised that
the subject did not demonstrate a more marked
hyperventilation, particularly since there was a
reduction in pH from 7.45 at rest to 7.24 at max-
imal exercise and an increase in arterial lactate
from 0.53 to 9.98 mM (Table 2). The combined
effect of hypoxia and exercise elicited a more
robust ventilatory response, as indicated by the
reduction in PaCO2 to 30.1 mmHg. However,
the maximal workload was also reduced sub-
stantially in hypoxia (Fig. 2).
DISCUSSION
We found that a young subject with a history
of BPD and a documented case of HAPE de-
veloped an excessively widened AaDO2 and 
arterial hypoxemia at V˙O2’s of 41.4 mL/
kg/min and 21.9 mL/kg/min during normoxic
and hypoxic exercise, respectively. These de-
grees of EIAH are typically not seen at these
metabolic rates (Dempsey and Wagner, 1999).
In healthy humans, the AaDO2 at rest is typi-
cally 5 to 10 mmHg, which increases to 20 to
25 mmHg at maximal exercise (Dempsey and
TABLE 1. ANTHROPOMETRIC METABOLIC RATE, DIFFUSION CAPACITY, AND PULMONARY FUNCTION DATA
Age, yr 27
Height, cm 187
Weight, kg 86.5
DLCO, mL/min/mmHg 36.2 (91.2)
VO2max, mL/kg/min, normoxia 41.4 (92.2)
VO2max, mL/kg/min, hypoxia 21.9
Pulmonary function Pre-albuterol Post-albuterol
FVC, L 6.13 (98.1) 6.47 (103.5)
FEV1, L 3.46 (66.5) 3.83 (73.7)0
FEV1/FVC 0.56 (66.9) 0.59 (70.7)0
FEF50, L/s 2.16 (34.3) 2.34 (37.2)0
Values in parentheses are percent predicted. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; FEF50,
forced expiratory flow at 50% of vital capacity; DLCO, diffusion capacity for carbon monoxide.
Calculations used for determination of percent predicted values were from Knudson et al. (1983), Knudson et al.
(1987), and Bruce et al. (1973).
FIG. 1. Gas exchange efficiency at rest and during nor-
moxic and hypoxic exercise. Open symbol indicates no
intrapulmonary shunting. Filled symbols indicate intra-
pulmonary shunting of contrast microbubbles.
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Wagner, 1999). The causes for the increased
AaDO2 during exercise include ventilation to
perfusion (V˙A/Q˙) heterogeneity, diffusion lim-
itation, extrapulmonary shunt (Dempsey and
Wagner, 1999) and, although controversial, in-
trapulmonary shunt (Eldridge et al., 2004;
Stickland et al., 2004). Typically, HAPE-s sub-
jects have neither abnormal resting pulmonary
function (Selland et al., 1993; Eldridge et al.,
1996) nor gas exchange disturbance at rest in
normoxia (Podolsky et al., 1996). Although
V˙A/Q˙ heterogeneity is increased slightly dur-
ing normoxic and hypoxic exercise (85% of
V˙O2max) in HAPE-s individuals compared to con-
trols (Podolsky et al., 1996), AaDO2 at maximal
exercise is not significantly different.
Our subject with a history of BPD had ab-
normal resting pulmonary function and exces-
sive gas exchange impairment during nor-
moxic and hypoxic exercise, which is atypical
for HAPE-s subjects. In normoxic exercise, our
subject demonstrated a surprisingly weak hy-
perventilatory response to exercise (PaCO2 of
38.7 mmHg), despite a significant increase in
lactate and a significant decrease in pH. We did
not measure flow volume loops during exer-
cise, so we do not know if the subject was flow
limited during exercise. However, in normoxia
the VE/VCO2 slope was 24.6 and the value at
the lactate threshold was 27.1, suggesting that
the hyperventilation was adequate (Wasser-
man et al., 1999), despite the reduction in PaO2.
Furthermore, with hypoxic exercise, the subject
clearly demonstrated an increase in ventilation
compared to normoxic exercise, as evidenced
by a reduction in PaCO2 to 30.1 mmHg. The fur-
ther increase in ventilation with hypoxic exer-
cise was likely caused by the combined hypoxic
and exercise stimuli, which would result in
greater hyperventilation in hypoxic exercise
compared to normoxic exercise (Pugh et al.,
1964). These data suggest that our subject may
have altered chemoreflexes. Indeed, it is known
that patients with BPD have blunted and ab-
normal chemoreflex responses (Garg et al.,
1988; Calder et al., 1994).
Patients who survive BPD have poor resting
pulmonary function (Hjalmarson and Sand-
berg, 2005) and abnormal alveolar and pul-
monary vascular development (Stenmark and
Abman, 2005). These characteristic features of
BPD would likely have an effect on V˙A/Q˙
matching and equilibration of oxygen between
the alveoli and pulmonary capillaries that
would impair gas exchange efficiency and ex-
acerbate arterial hypoxemia during hyperdy-
namic states such as exercise. Indeed, Wagner
et al. (1996) demonstrated an increase in V˙A/Q˙
FIG. 2. Arterial blood gases at rest and during normoxic
and hypoxic exercise.
TABLE 2. METABOLIC RATE DATA AND BLOOD GAS
Normoxia Hypoxia
Rest Max Rest Max
VO2 (mL/kg/min) 4.800 41.400 6.000 21.900
PaCO2 (mmHg) 36.700 38.700 35.900 30.100
PaO2 (mmHg) 100.200 67.800 39.900 29.900
SaO2 (%) 1000.00 89000. 81000. 64000.
HCO3 (mmol/L) 26.250 16.730 26.850 20.250
pH 7.447 7.240 7.464 7.425
Lactate (mmol/L) 0.530 9.980 0.660 5.410
Temperature (°C) 37.300 37.900 36.900 37000.
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heterogeneity at rest in asthmatic subjects with
a similar degree of mid-expiratory flow limita-
tion as that in our subject. Furthermore,
Mitchell and Teague (1998) reported a reduc-
tion in DLCO during exercise in adolescent chil-
dren with a history of BPD compared to ado-
lescents with prematurity, but without a
history of BPD. In combination, these findings
suggest that a history of BPD may predispose
individuals to excessive gas exchange ineffi-
ciency during exercise.
Contrary to our hypothesis, the subject
demonstrated intrapulmonary arteriovenous
shunting during normoxic exercise. Interest-
ingly, with hypoxia, intrapulmonary arteriove-
nous shunting was present at rest and persisted
throughout exercise. Previously, we and others
have reported that transpulmonary passage of
microbubbles does not typically occur at rest in
healthy human subjects in normoxia (Eldridge
et al., 2004; Stickland et al., 2004). The opening
of these intrapulmonary arteriovenous path-
ways at rest while breathing 12% O2 suggests
that O2 tension may be important in the regu-
lation of these unique vascular pathways. In-
trapulmonary shunting is a likely contributor
to the gas exchange inefficiency that occurred
in our subject.
We did not assess the pulmonary vascular
responses to hypoxia and exercise in our sub-
ject. However, patients with BPD are known
to have abnormalities of the pulmonary cir-
culation, including elevated pulmonary vas-
cular resistance and abnormal vasoreactivity
(Mourani et al., 2004). Furthermore, decreased
angiogenesis may limit pulmonary vascular
surface area, resulting in further elevations in
pulmonary resistance and impaired gas ex-
change. However, the VE/VCO2 slope data ob-
tained in our subject were within the normal
range of healthy human subjects, whereas an
individual with pulmonary vascular disease
would be expected to have a significantly
steeper VE/VCO2 slope (Wasserman et al.,
1999).
We present a subject with a history of BPD
who rapidly developed HAPE at a modest alti-
tude. The subject was found to have significant
airway obstruction at rest, exercise-induced in-
trapulmonary shunting, and excessive gas ex-
change impairment during both normoxic and
hypoxic exercise. Other abnormalities associ-
ated with BPD that may increase the risk for
significant altitude illness include blunted
chemoreflexes, pulmonary hypertension, a
brisk hypoxic pulmonary pressor response,
and an augmented flow-dependent pulmonary
vascular reactivity. In summary, individuals
with BPD should be advised accordingly be-
fore going to moderate or high altitudes.
ACKNOWLEDGMENTS
We thank Jaime L. Beebe and David F.
Pegelow for excellent technical assistance. We
thank Drs. Jerome A. Dempsey, Michael K.
Stickland, and Christopher G. Green for criti-
cal review. Support for this project was pro-
vided by a National Heart, Lung, and Blood
Institute (NHLBI) Grant HL-15469, a Grant-in-
Aid from the American Heart Association,
0550176Z, and the Department of Pediatrics,
University of Wisconsin, Madison. H.C. Haver-
kamp and A.T. Lovering were supported by a
NHLBI Training Grant, T32 HL07654.
REFERENCES
American Thoracic Society. (1995). American Thoracic So-
ciety Standardization of Spirometry, 1995. 1994 update.
Am. J. Respir. Crit. Care Med. 152:1107–1136.
Bartsch, P., Mairbaurl, H., Maggiorini, M., and Swenson,
E.R. (2005). Physiological aspects of high-altitude pul-
monary edema. J. Appl. Physiol. 98:1101–1110.
Bhandari, A., and Bhandari, V. (2003). Pathogenesis,
pathology and pathophysiology of pulmonary seque-
lae of bronchopulmonary dysplasia in premature in-
fants. Front. Biosci. 8:e370–e380.
Bhatt, A.J., Pryhuber, G.S., Huyck, H., Watkins, R.H., Met-
lay, L.A., and Maniscalco, W.M. (2001). Disrupted pul-
monary vasculature and decreased vascular endothe-
lial growth factor, Flt-1, and TIE-2 in human infants
dying with bronchopulmonary dysplasia. Am. J.
Respir. Crit. Care Med. 164:1971–1980.
Bruce, R.A., Kusumi, F., and Hosmer, D. (1973). Maximal
oxygen intake and nomographic assessment of func-
tional aerobic impairment in cardiovascular disease.
Am. Heart J. 85:546–562.
Calder, N.A., Williams, B.A., Smyth, J., Boon, A.W., Ku-
mar, P., and Hanson, M.A. (1994). Absence of ventila-
tory responses to alternating breaths of mild hypoxia
and air in infants who have had bronchopulmonary
dysplasia: implications for the risk of sudden infant
death. Pediatr. Res. 35:677–681.
GAS EXCHANGE IMPAIRMENT IN A HAPE-SUSCEPTIBLE SUBJECT 67
Dempsey, J.A., and Wagner, P.D. (1999). Exercise-induced
arterial hypoxemia. J. Appl. Physiol. 87:1997–2006.
Eldridge, M.W., Dempsey, J.A., Haverkamp, H.C., Lover-
ing, A.T., and Hokanson, J.S. (2004). Exercise-induced
intrapulmonary arteriovenous shunting in healthy hu-
mans. J. Appl. Physiol. 97:797–805.
Eldridge, M.W., Podolsky, A., Richardson, R.S., Johnson,
D.H., Knight, D.R., Johnson, E.C., Hopkins, S.R.,
Michimata, H., Grassi, B., Feiner, J., Kurdak, S.S., Bick-
ler, P.E., Wagner, P.D., and Severinghaus, J.W. (1996).
Pulmonary hemodynamic response to exercise in sub-
jects with prior high-altitude pulmonary edema. J.
Appl. Physiol. 81:911–921.
Garg, M., Kurzner, S.I., Bautista, D., and Keens, T.G.
(1988). Hypoxic arousal responses in infants with bron-
chopulmonary dysplasia. Pediatrics 82:59–63.
Hjalmarson, O., and Sandberg, K.L. (2005). Lung function
at term reflects severity of bronchopulmonary dyspla-
sia. J. Pediatr. 146:86–90.
Knudson, R.J., Kaltenborn, W.T., Knudson, D.E., and Bur-
rows, B. (1987). The single-breath carbon monoxide dif-
fusing capacity. Reference equations derived from a
healthy nonsmoking population and effects of hemat-
ocrit. Am. Rev. Respir. Dis. 135:805–811.
Knudson, R.J., Lebowitz, M.D., Holberg, C.J., and Bur-
rows, B. (1983). Changes in the normal maximal expi-
ratory flow–volume curve with growth and aging. Am.
Rev. Respir. Dis. 127:725–734.
Margraf, L.R., Tomashefski, J.F., Jr., Bruce, M.C., and
Dahms, B.B. (1991). Morphometric analysis of the lung
in bronchopulmonary dysplasia. Am. Rev. Respir. Dis.
143:391–400.
Mitchell, S.H., and Teague, W.G. (1998). Reduced gas
transfer at rest and during exercise in school-age sur-
vivors of bronchopulmonary dysplasia. Am. J. Respir.
Crit. Care Med. 157:1406–1412.
Mourani, P.M., Ivy, D.D., Gao, D., and Abman, S.H.
(2004). Pulmonary vascular effects of inhaled nitric ox-
ide and oxygen tension in bronchopulmonary dyspla-
sia. Am. J. Respir. Crit. Care Med. 170:1006–1013.
Parker, T.A., and Abman, S.H. (2003). The pulmonary cir-
culation in bronchopulmonary dysplasia. Semin.
Neonatol. 8:51–61.
Podolsky, A., Eldridge, M.W., Richardson, R.S., Knight,
D.R., Johnson, E.C., Hopkins, S.R., Johnson, D.H.,
Michimata, H., Grassi, B., Feiner, J., Kurdak, S.S., Bick-
ler, P.E., Severinghaus, J.W., and Wagner, P.D. (1996).
Exercise-induced VA/Q inequality in subjects with
prior high-altitude pulmonary edema. J. Appl. Physiol.
81:922–932.
Pugh, L.G., Gill, M.B., Lahiri, S., Milledge, J.S., Ward,
M.P., and West, J.B. (1964). Muscular exercise at great
altitudes. J. Appl. Physiol. 19:431–440.
Schoene, R.B. (2004). Unraveling the mechanism of high
altitude pulmonary edema. High Alt. Med. Biol.
5:125–135.
Selland, M.A., Stelzner, T.J., Stevens, T., Mazzeo, R.S., Mc-
Cullough, R.E., and Reeves, J.T. (1993). Pulmonary
function and hypoxic ventilatory response in subjects
susceptible to high-altitude pulmonary edema. Chest
103:111–116.
Stenmark, K.R., and Abman, S.H. (2005). Lung vascular
development: implications for the pathogenesis of
bronchopulmonary dysplasia. Annu. Rev. Physiol.
67:623–661.
Stickland, M.K., Welsh, R.C., Haykowsky, M.J., Petersen,
S.R., Anderson, W.D., Taylor, D.A., Bouffard, M., and
Jones, R.L. (2004). Intra-pulmonary shunt and pul-
monary gas exchange during exercise in humans. J.
Physiol. 561:321–329.
Wagner, P.D., Hedenstierna, G., and Rodriguez-Roisin, R.
(1996). Gas exchange, expiratory flow obstruction and
the clinical spectrum of asthma. Eur. Respir. J.
9:1278–1282.
Wasserman, K., Hansen, J.E., Sue, D.Y., Casaburi, R., and
Whipp, B.J. (1999). Clinical applications of cardiopul-
monary exercise testing. In: Principles of Exercise Test-
ing and Interpretation. Lippincot Williams and Wilkins,
Philadelphia; pp. 178–214.
Address reprint requests to:
Andrew T. Lovering
John Rankin Laboratory of Pulmonary Medicine
University of Wisconsin Medical School
Department of Population Health Sciences
Room 4245 MSC, 1300 University
Madison, WI 53706-1532
E-mail: atlovering@wisc.edu
Received June 14, 2006; accepted in final
form October 20, 2006.
